Tearsheet
RCMT Home Investment Highlights Valuation, Metrics & Events Price Chart Why The Stock Moved Return vs. Risk About RCMT Interactive Breakdown Better Bets vs. RCMT Latest Trefis Analyses Trade Ideas More From Trefis Peer Comparisons FDIC Bank Data FDA Approved Drugs Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Forward Guidance Insider Activity Trade Sentinel Industry Resource Links External Quote Links

RCM Technologies (RCMT)

Market Price (4/16/2026): $29.92 | Market Cap: $220.4 Mil
Sector: Industrials | Industry: Industrial Conglomerates

RCM Technologies (RCMT)

Market Price (4/16/2026): $29.92
Market Cap: $220.4 Mil
Sector: Industrials
Industry: Industrial Conglomerates

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.4%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.1%, FCF Yield is 7.9%

Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 15%

Megatrend and thematic drivers
Megatrends include Cloud Computing, Cybersecurity, and Artificial Intelligence. Themes include Hybrid Cloud Solutions, Show more.

Trading close to highs
Dist 52W High is 0.0%

Key risks
RCMT key risks include [1] its heavy concentration of revenue from a limited number of customers and specific business segments, Show more.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.4%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.1%, FCF Yield is 7.9%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 15%
2 Megatrend and thematic drivers
Megatrends include Cloud Computing, Cybersecurity, and Artificial Intelligence. Themes include Hybrid Cloud Solutions, Show more.
3 Trading close to highs
Dist 52W High is 0.0%
4 Key risks
RCMT key risks include [1] its heavy concentration of revenue from a limited number of customers and specific business segments, Show more.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

RCM Technologies (RCMT) stock has gained about 45% since 12/31/2025 because of the following key factors:

1. RCM Technologies reported exceptionally strong financial results for the fourth quarter and full fiscal year 2025, significantly exceeding prior-year performance.

For the fourth quarter ended January 3, 2026, revenue increased by 12.4% year-over-year to $86.5 million. GAAP net income surged by 112.5% to $6.1 million, resulting in $0.80 diluted earnings per share, up from $0.37 in the comparable prior quarter. Additionally, adjusted EBITDA for the quarter rose by 49.0% to $9.3 million.

2. Analysts issued positive upgrades and raised price targets for RCM Technologies following the strong earnings report.

Benchmark raised its price target on RCM Technologies from $32.00 to $36.00 and maintained a "Buy" rating on April 8, 2026, citing the Q4 beat driven by stronger operating leverage. On April 15, 2026, Zacks Research upgraded RCM Technologies from a "hold" rating to a "strong-buy" rating. The consensus among analysts currently stands at a "Buy" rating with an average price target of $36.00.

Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 46.3% change in RCMT stock from 12/31/2025 to 4/15/2026 was primarily driven by a 21.0% change in the company's Net Income Margin (%).
(LTM values as of)123120254152026Change
Stock Price ($)20.4529.9146.3%
Change Contribution By: 
Total Revenues ($ Mil)3103193.1%
Net Income Margin (%)4.2%5.1%21.0%
P/E Multiple11.613.516.6%
Shares Outstanding (Mil)770.6%
Cumulative Contribution46.3%

LTM = Last Twelve Months as of date shown

Market Drivers

12/31/2025 to 4/15/2026
ReturnCorrelation
RCMT46.3% 
Market (SPY)-5.4%41.9%
Sector (XLI)10.4%13.5%

Fundamental Drivers

The 12.7% change in RCMT stock from 9/30/2025 to 4/15/2026 was primarily driven by a 12.9% change in the company's Net Income Margin (%).
(LTM values as of)93020254152026Change
Stock Price ($)26.5529.9112.7%
Change Contribution By: 
Total Revenues ($ Mil)3003196.5%
Net Income Margin (%)4.5%5.1%12.9%
P/E Multiple14.513.5-6.8%
Shares Outstanding (Mil)770.6%
Cumulative Contribution12.7%

LTM = Last Twelve Months as of date shown

Market Drivers

9/30/2025 to 4/15/2026
ReturnCorrelation
RCMT12.7% 
Market (SPY)-2.9%33.1%
Sector (XLI)11.4%18.3%

Fundamental Drivers

The 91.7% change in RCMT stock from 3/31/2025 to 4/15/2026 was primarily driven by a 51.6% change in the company's P/E Multiple.
(LTM values as of)33120254152026Change
Stock Price ($)15.6029.9191.7%
Change Contribution By: 
Total Revenues ($ Mil)27831914.7%
Net Income Margin (%)4.8%5.1%6.8%
P/E Multiple8.913.551.6%
Shares Outstanding (Mil)873.2%
Cumulative Contribution91.7%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2025 to 4/15/2026
ReturnCorrelation
RCMT91.7% 
Market (SPY)16.3%32.2%
Sector (XLI)32.0%26.5%

Fundamental Drivers

The 158.7% change in RCMT stock from 3/31/2023 to 4/15/2026 was primarily driven by a 151.5% change in the company's P/E Multiple.
(LTM values as of)33120234152026Change
Stock Price ($)11.5629.91158.7%
Change Contribution By: 
Total Revenues ($ Mil)28531912.2%
Net Income Margin (%)7.3%5.1%-30.3%
P/E Multiple5.413.5151.5%
Shares Outstanding (Mil)10731.5%
Cumulative Contribution158.7%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2023 to 4/15/2026
ReturnCorrelation
RCMT158.7% 
Market (SPY)63.3%26.6%
Sector (XLI)76.4%26.4%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
RCMT Return244%73%135%-24%-8%39%1278%
Peers Return44%-17%8%-10%-19%-9%-14%
S&P 500 Return27%-19%24%23%16%2%85%

Monthly Win Rates [3]
RCMT Win Rate75%42%75%50%50%75% 
Peers Win Rate73%43%52%48%47%30% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
RCMT Max Drawdown-10%-18%-16%-38%-33%-14% 
Peers Max Drawdown-7%-28%-17%-21%-30%-16% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-7% 

[1] Cumulative total returns since the beginning of 2021
[2] Peers: AMN, CTSH, KBR, J, ASGN.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 4/15/2026 (YTD)

How Low Can It Go

Unique KeyEventRCMTS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-63.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven171.3%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven269 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-62.9%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven169.6%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven322 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-58.5%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven141.0%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven647 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-91.2%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven1035.2%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven4,754 days1,480 days

Compare to AMN, CTSH, KBR, J, ASGN

In The Past

RCM Technologies's stock fell -63.1% during the 2022 Inflation Shock from a high on 6/3/2022. A -63.1% loss requires a 171.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About RCM Technologies (RCMT)

RCM Technologies, Inc. provides business and technology solutions in the United States, Canada, Puerto Rico, and Serbia. It operates through three segments: Engineering, Specialty Health Care, and Life Sciences and Information Technology. The Engineering segment offers a range of engineering services, including project management engineering and design, engineering analysis, engineer-procure-construct, configuration management, hardware/software validation and verification, quality assurance, technical writing and publications, manufacturing process planning and improvement, and 3D/BIM integrated design. The Specialty Health Care segment provides long-term and short-term staffing, executive search, and placement services in the fields of allied and therapy staffing, correctional healthcare staffing, health information management, nursing services, physician and advanced practice, school services, and telepractice. The Life Sciences and Information Technology segment provides enterprise business solutions, application services, infrastructure solutions, competitive advantage, life sciences solutions, and other vertical market specific solutions. The company serves aerospace and defense, energy, financial services, health care, life sciences, manufacturing and distribution, and technology industries, as well as educational institutions and the public sector. RCM Technologies, Inc. was founded in 1971 and is based in Pennsauken, New Jersey.

AI Analysis | Feedback

Here are 1-3 brief analogies for RCM Technologies (RCMT):

  • Imagine a smaller, specialized version of Accenture, providing a mix of technology, engineering, and business solutions, alongside extensive healthcare staffing services.

  • Think of a blend between AMN Healthcare (for its specialized medical staffing) and an engineering and IT consulting firm like Capgemini.

AI Analysis | Feedback

  • Engineering Services: Provides a full spectrum of engineering support, including design, analysis, project management, and technical documentation for various industries.
  • Healthcare Staffing and Recruitment: Offers temporary and permanent placement of healthcare professionals, therapists, nurses, and physicians across diverse healthcare settings.
  • IT and Life Sciences Solutions: Delivers comprehensive information technology services, such as enterprise business solutions, application development, infrastructure management, and specialized life sciences technology support.

AI Analysis | Feedback

RCM Technologies (RCMT) primarily sells its business and technology solutions, as well as staffing services, to other companies and organizations.

Based on the provided company description, specific major customer company names are not disclosed. However, RCM Technologies serves a diverse client base across numerous industries and sectors. Its major customers can be categorized by the industries and types of organizations it serves, which include:

  • Aerospace and Defense industry
  • Energy industry
  • Financial Services industry
  • Health Care industry
  • Life Sciences industry
  • Manufacturing and Distribution industry
  • Technology industry
  • Educational Institutions
  • The Public Sector

AI Analysis | Feedback

null

AI Analysis | Feedback

```html

Bradley S. Vizi, Executive Chairman & President

Bradley S. Vizi is a primary force in the governance and strategy of RCM Technologies, Inc., holding a substantial individual ownership stake in the company. He is the largest individual shareholder, owning 19% of the outstanding shares as of July 3, 2025. Mr. Vizi has emphasized the importance of share count reductions to improve shareholder returns and has overseen significant share buybacks. He has been actively involved in the company's leadership for an extended period.

Kevin D. Miller, Chief Financial Officer, Treasurer, Principal Accounting Officer and Secretary

Kevin D. Miller has served as the Chief Financial Officer, Secretary, and Treasurer at RCM Technologies Inc. since October 2008. Prior to this role, he was the Senior Vice President of RCM from July 1997 to September 2008. Mr. Miller also worked as an Associate in the Corporate Finance Department of Legg Mason Wood Walker, Incorporated from 1996 to 1997, and as a Business Consultant for the Wharton Small Business Development Center from 1995 to 1996. His earlier experience includes serving as an Associate in both the audit and corporate finance groups at Ernst & Young LLP.

Michael Saks, Division President, Health Care Services

Michael Saks oversees the Health Care Services segment, which generates the majority of RCM Technologies' revenue.

Tina Ciocca, Executive Vice President, Aerospace & Defense

Tina Ciocca holds the position of Executive Vice President, Aerospace & Defense at RCM Technologies.

William Gargano, Group Senior Vice President, Life Sciences & IT Services

William Gargano serves as the Group Senior Vice President for the Life Sciences & IT Services segment of RCM Technologies.

```

AI Analysis | Feedback

Here are the key risks to the business of RCM Technologies (RCMT):

  1. Economic Factors, Market Demand Fluctuations, and Wage Inflation: RCM Technologies is significantly exposed to the broader economic environment, which can impact client capital expenditure budgets and demand for its services. Persistent inflation and high interest rates have been noted to pressure capital expenditure for IT and Engineering clients, leading to a slowdown in discretionary IT/Consulting and Life Sciences & Data Solutions. The company's gross profit in the Life Sciences & Data Solutions segment declined by 4.2% year-over-year in Q3 2025. Furthermore, the Specialty Health Care segment experienced an 11% decline in revenue due to reduced demand for travel nurse services and challenging comparisons to prior COVID-related revenues. Wage inflation, particularly in the nursing sector, also squeezes profit margins. Operational inefficiencies, reflected in lower utilization rates, have also contributed to a decrease in gross margin.

  2. Cybersecurity Threats and Data Privacy: As a provider of technology solutions, RCM Technologies faces ongoing risks from cybersecurity threats. If realized, these threats could materially affect the company's operations, business strategy, results of operations, or financial condition. The company's 10-K filings explicitly mention risks related to cybersecurity, data privacy, data center capacity, and telecommunication links.

  3. Dependence on a Concentrated Group of Customers: A significant portion of RCM Technologies' condensed consolidated revenues is contributed by a concentrated group of customers. This customer concentration poses a risk, as the loss of one or more major clients or a significant reduction in business from them could materially and adversely affect the company's financial performance and results of operations.

AI Analysis | Feedback

The emergence of advanced AI and machine learning-driven staffing platforms and recruitment technologies poses a clear threat to RCM Technologies' Specialty Health Care segment. These platforms automate candidate sourcing, matching, and screening, potentially offering faster, more cost-effective, and efficient recruitment solutions that could disintermediate traditional human-centric staffing agencies.

Additionally, the rapid advancements in hyper-automation, AI-powered development tools (e.g., low-code/no-code platforms, generative AI for code), and increasingly integrated cloud-native services from major providers threaten to commoditize or significantly alter the demand for traditional enterprise business solutions, application services, and infrastructure solutions within RCM Technologies' Life Sciences and Information Technology segment. This could reduce the need for human-intensive IT services that RCMT currently provides, shifting value towards highly specialized consulting or platform-specific integration.

AI Analysis | Feedback

RCM Technologies operates within three main segments, each addressing significant market opportunities:

  • Engineering: The global engineering services market was valued at approximately USD 2.34 trillion in 2025 and is projected to grow to USD 5.37 trillion by 2034, exhibiting a compound annual growth rate (CAGR) of 10.60% from 2026 to 2034. For the U.S. specifically, the market size was estimated at USD 0.45 trillion in 2026.
  • Specialty Health Care: The U.S. healthcare staffing market, which includes long-term and short-term staffing, executive search, and placement services, was estimated at USD 45.48 billion in 2025. It is projected to reach USD 89.71 billion by 2033, growing at a CAGR of 6.98% from 2026 to 2033.
  • Life Sciences and Information Technology: This segment encompasses two primary areas:
    • Life Sciences IT/Software: The global life sciences IT market was estimated at USD 25.45 billion in 2024 and is expected to reach USD 69.01 billion in 2034, expanding at a CAGR of 10.49% over the forecast period of 2025-2034. In North America, the market was valued at US$ 35.42 billion in 2024 and is anticipated to reach approximately US$ 110.75 billion by 2034, expanding at a CAGR of 12.08% from 2025 to 2034.
    • IT Consulting Services: The global IT consulting services market was valued at approximately USD 78.03 billion in 2024 and is projected to reach USD 129.15 billion by 2034, growing at a CAGR of roughly 6.50% between 2025 and 2034.

AI Analysis | Feedback

RCM Technologies (RCMT) is expected to drive future revenue growth over the next 2-3 years through several key initiatives across its segments:

  1. Expansion of Specialty Health Care Services: The company anticipates continued growth in its Specialty Health Care segment, particularly in school-related services. This growth is projected to be around 20% for the school year spanning July 2024 to June 2025, supported by the acquisition of over 20 new school contracts. Additionally, RCM Technologies is broadening its K-12 behavioral health services and Health Information Management (HIM) offerings, and it possesses a robust pipeline of international nurses expected to accelerate growth in both healthcare and education sectors.
  2. Growth in Engineering Services from Infrastructure and Aerospace: RCM Technologies is well-positioned for growth in its Engineering segment, leveraging significant trends such as grid modernization and data center expansion. The company has secured multi-year preferred partner agreements for comprehensive engineering services and has a record engineering backlog of over $70 million for 2026, a substantial increase from the prior year. Its Aerospace Group also demonstrated strong performance, exceeding its Q1 2025 business plan objectives by over 20% in revenue.
  3. Advancements and New Client Acquisition in Life Sciences and Information Technology: The Life Sciences and Information Technology segment is expected to grow through high-value managed service offerings, particularly in commercialization, data integrity, and quality improvement programs. RCM Technologies is actively securing new clients in the pharmaceutical and biotech sectors and is investing in AI-driven equipment qualification and data integrity solutions to streamline compliance and enhance audit readiness. The broader Revenue Cycle Management (RCM) market, relevant to their IT services, is also projected to grow significantly, driven by AI adoption.

AI Analysis | Feedback

Share Repurchases

  • RCM Technologies has consistently repurchased shares over the last 3-5 years, leading to a significant reduction in common shares outstanding. The number of shares outstanding decreased from 10.29 million at the end of 2021 to 7.41 million at the end of 2025.
  • In the last year, the number of shares outstanding decreased by 4.33%.

Share Issuance

  • There have been no significant share issuances over the last 3-5 years, with the overall trend showing a decrease in outstanding shares.

Capital Expenditures

  • Capital expenditures were $3 million in 2023 and $3 million in 2024.
  • In the last 12 months, capital expenditures totaled -$2.38 million.
  • Capital expenditures are projected to be $2 million annually from 2025 to 2029, representing approximately 1% of revenue.

Better Bets vs. RCM Technologies (RCMT)

Latest Trefis Analyses

Title
0ARTICLES

Trade Ideas

Select ideas related to RCMT.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
NSP_3312026_Insider_Buying_45D_2Buy_200K03312026NSPInsperityInsiderInsider Buys 45DStrong Insider Buying
Companies with multiple insider buys in the last 45 days		0.0%0.0%0.0%
TNC_3312026_Insider_Buying_45D_2Buy_200K03312026TNCTennantInsiderInsider Buys 45DStrong Insider Buying
Companies with multiple insider buys in the last 45 days		0.0%0.0%0.0%
ADP_3272026_Dip_Buyer_FCFYield03272026ADPAutomatic Data ProcessingDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		1.0%1.0%0.0%
HURN_3272026_Dip_Buyer_FCFYield03272026HURNHuron ConsultingDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		4.0%4.0%0.0%
TRU_3272026_Dip_Buyer_FCFYield03272026TRUTransUnionDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		5.2%5.2%0.0%

Recent Active Movers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons

Peers to compare with:

Financials

RCMTAMNCTSHKBRJASGNMedian
NameRCM Tech.AMN Heal.Cognizan.KBR Jacobs S.ASGN  
Mkt Price29.9119.3760.3936.70127.3139.0537.88
Mkt Cap0.20.828.94.615.11.73.1
Rev LTM3192,73021,1087,82312,3903,9805,902
Op Inc LTM25333,327561888230396
FCF LTM172342,595515875288402
FCF 3Y Avg102472,145380824357368
CFO LTM192692,883557960328442
CFO 3Y Avg133212,446436932395415

Growth & Margins

RCMTAMNCTSHKBRJASGNMedian
NameRCM Tech.AMN Heal.Cognizan.KBR Jacobs S.ASGN  
Rev Chg LTM14.7%-8.5%7.0%1.5%6.6%-2.9%4.0%
Rev Chg 3Y Avg4.3%-19.2%2.8%6.1%7.0%-4.5%3.6%
Rev Chg Q12.4%1.8%4.9%-10.6%12.3%-0.5%3.4%
QoQ Delta Rev Chg LTM3.1%0.5%1.2%-2.8%3.0%-0.1%0.9%
Op Mgn LTM7.9%1.2%15.8%7.2%7.2%5.8%7.2%
Op Mgn 3Y Avg8.1%4.8%15.4%7.1%6.5%7.1%7.1%
QoQ Delta Op Mgn LTM0.7%-0.4%0.1%0.4%-0.0%-0.4%0.0%
CFO/Rev LTM5.9%9.9%13.7%7.1%7.7%8.2%8.0%
CFO/Rev 3Y Avg4.3%10.1%12.2%5.8%8.4%9.4%8.9%
FCF/Rev LTM5.4%8.6%12.3%6.6%7.1%7.2%7.2%
FCF/Rev 3Y Avg3.5%7.9%10.7%5.0%7.4%8.5%7.7%

Valuation

RCMTAMNCTSHKBRJASGNMedian
NameRCM Tech.AMN Heal.Cognizan.KBR Jacobs S.ASGN  
Mkt Cap0.20.828.94.615.11.73.1
P/S0.70.31.40.61.20.40.6
P/EBIT8.9-13.58.26.017.97.27.7
P/E13.5-7.813.011.134.914.613.2
P/CFO11.62.810.08.315.75.19.2
Total Yield7.4%-12.8%8.2%10.8%3.4%6.8%7.1%
Dividend Yield0.0%0.0%0.5%1.8%0.5%0.0%0.3%
FCF Yield 3Y Avg7.0%24.6%5.6%6.1%5.1%11.0%6.6%
D/E0.11.10.00.60.20.70.4
Net D/E0.11.0-0.00.50.10.60.3

Returns

RCMTAMNCTSHKBRJASGNMedian
NameRCM Tech.AMN Heal.Cognizan.KBR Jacobs S.ASGN  
1M Rtn52.7%3.7%-1.1%0.4%-1.2%7.2%2.0%
3M Rtn46.8%-0.9%-30.0%-16.3%-8.2%-20.9%-12.2%
6M Rtn28.8%-5.6%-8.7%-16.1%-20.3%-15.6%-12.2%
12M Rtn86.2%2.2%-13.7%-25.9%10.5%-33.7%-5.8%
3Y Rtn146.8%-77.7%5.8%-32.7%38.2%-49.9%-13.5%
1M Excs Rtn47.9%-1.1%-5.9%-4.4%-6.0%2.4%-2.8%
3M Excs Rtn48.0%25.6%-29.0%-17.1%-9.4%-20.8%-13.2%
6M Excs Rtn22.1%-4.5%-13.6%-22.8%-22.4%-22.3%-17.9%
12M Excs Rtn57.3%-29.6%-43.3%-56.9%-19.5%-66.0%-36.5%
3Y Excs Rtn84.1%-147.8%-67.0%-102.8%-31.4%-121.9%-84.9%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Specialty Health Care136159986089
Engineering8586665868
Life Sciences, Data & Solutions4239   
Corporate00   
Information Technology  393234
Total263285204150191


Operating Income by Segment
$ Mil20252024202320222021
Specialty Health Care14205-33
Life Sciences, Data & Solutions75   
Engineering445-64
Corporate00 -2-0
Information Technology  3-00
Total242914-117


Assets by Segment
$ Mil20252024202320222021
Engineering4633283452
Specialty Health Care4434331930
Life Sciences, Data & Solutions1916   
Corporate125386
Information Technology  978
Total12088736896


Price Behavior

Price Behavior
Market Price$29.91 
Market Cap ($ Bil)0.2 
First Trading Date08/18/1995 
Distance from 52W High0.0% 
   50 Days200 Days
DMA Price$20.44$22.41
DMA Trendindeterminateup
Distance from DMA46.3%33.5%
 3M1YR
Volatility77.9%52.2%
Downside Capture-0.400.18
Upside Capture169.36104.02
Correlation (SPY)22.2%24.4%
RCMT Betas & Captures as of 3/31/2026

 1M2M3M6M1Y3Y
Beta1.571.031.210.990.690.77
Up Beta3.94-0.181.291.760.760.72
Down Beta0.610.360.821.020.330.67
Up Capture290%170%154%31%85%72%
Bmk +ve Days7162765139424
Stock +ve Days10192850110353
Down Capture107%128%124%113%89%95%
Bmk -ve Days12233358110323
Stock -ve Days12233576140391

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return		Annualized
Volatility		Sharpe
Ratio		Correlation
with RCMT
RCMT76.6%51.7%1.26-
Sector ETF (XLI)37.8%15.3%1.8925.2%
Equity (SPY)22.0%12.9%1.3634.5%
Gold (GLD)49.0%27.5%1.44-7.4%
Commodities (DBC)25.0%16.1%1.380.7%
Real Estate (VNQ)17.3%13.7%0.9211.4%
Bitcoin (BTCUSD)-10.4%42.6%-0.1420.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return		Annualized
Volatility		Sharpe
Ratio		Correlation
with RCMT
RCMT51.6%63.0%0.91-
Sector ETF (XLI)13.1%17.3%0.6021.8%
Equity (SPY)10.9%17.0%0.5024.3%
Gold (GLD)21.9%17.8%1.01-3.0%
Commodities (DBC)11.5%18.8%0.505.7%
Real Estate (VNQ)4.0%18.8%0.1216.8%
Bitcoin (BTCUSD)5.1%56.5%0.3110.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return		Annualized
Volatility		Sharpe
Ratio		Correlation
with RCMT
RCMT20.0%65.8%0.54-
Sector ETF (XLI)14.0%19.9%0.6220.7%
Equity (SPY)13.8%17.9%0.6721.1%
Gold (GLD)14.3%15.9%0.75-1.3%
Commodities (DBC)8.7%17.6%0.417.1%
Real Estate (VNQ)5.4%20.7%0.2217.9%
Bitcoin (BTCUSD)67.8%66.9%1.0711.5%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date3312026
Short Interest: Shares Quantity0.3 Mil
Short Interest: % Change Since 315202612.2%
Average Daily Volume0.0 Mil
Days-to-Cover Short Interest5.8 days
Basic Shares Quantity7.4 Mil
Short % of Basic Shares3.9%

Returns Analyses

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/5/2025-5.0%-17.3%-14.2%
8/7/20250.0%8.7%20.8%
3/12/2025-13.5%-16.2%-8.9%
11/7/20244.2%-1.8%5.7%
8/7/20246.1%2.9%4.6%
3/13/2024-24.9%-19.0%-32.3%
11/8/202314.1%26.4%41.0%
8/9/2023-10.1%1.7%0.9%
...
SUMMARY STATS   
# Positive979
# Negative9119
Median Positive4.2%8.7%20.0%
Median Negative-6.7%-11.1%-11.6%
Max Positive14.9%41.3%103.7%
Max Negative-24.9%-19.0%-45.1%

SEC Filings

Expand for More
Report DateFiling DateFiling
12/31/202504/03/202610-K
09/30/202511/06/202510-Q
06/30/202508/07/202510-Q
03/31/202505/08/202510-Q
12/31/202403/13/202510-K
09/30/202411/07/202410-Q
06/30/202408/08/202410-Q
03/31/202405/09/202410-Q
12/31/202303/14/202410-K
09/30/202311/09/202310-Q
06/30/202308/10/202310-Q
03/31/202305/10/202310-Q
12/31/202203/16/202310-K
09/30/202211/10/202210-Q
06/30/202208/11/202210-Q
03/31/202204/28/202210-Q

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value		Value of
Held Shares		Form
1Vizi, BradleyExecutive Chairman & PresidentDirectSell1001202527.501604,40041,557,258Form
2Vizi, BradleyExecutive Chairman & PresidentDirectSell924202527.501,16532,03841,564,215Form
3Vizi, BradleyExecutive Chairman & PresidentDirectSell924202527.50852,33841,561,878Form
4Vizi, BradleyExecutive Chairman & PresidentDirectSell924202527.55822041,637,224Form
5Vizi, BradleyExecutive Chairman & PresidentDirectSell919202527.512,81177,33141,788,680Form

External Quote Links


Prefer one of these to Trefis? Tell us why.